A Baltimore biotech-wellness brand · $120K → $540K MRR.

The archetype represents a slice of Baltimore biotech-DTC we ship into reliably: a wellness supplement or science-led skincare operator spinning out of the Hopkins corridor, with founder-credibility tied to real R-and-D experience, selling direct-to-consumer to a buyer who reads ingredient panels before they read marketing copy. Pre-engagement state: $120K MRR on a Shopify Basic setup, product detail pages built for general-DTC buyers rather than evidence-first wellness buyers, no FDA-aware Supplement Facts panels, no real subscription mechanics on dose-cadence SKUs, and a Klaviyo program running three flows on default templates.

Three structural problems compounded the growth ceiling. One, the product detail pages did not surface the brand's R-and-D credibility (third-party studies, ingredient sourcing, dose-rationale) in the way wellness buyers expect; conversion sat at 1.4 percent against an industry baseline closer to 2.8 to 3.5 percent. Two, dose-cadence SKUs (the daily-supplement product line that buyers consume monthly) had no subscription product to attach to, leaving roughly 40 percent of plausible repeat revenue on the table. Three, Klaviyo's segmentation did not distinguish between the dose-cadence buyer cohort and the one-time-buyer cohort, so messaging cadences hurt rather than helped retention.

The pattern this archetype represents (Baltimore biotech-DTC or wellness supplement operator in the $80K to $250K MRR range, with credible R-and-D positioning, sitting on product detail pages built for general DTC rather than evidence-first wellness buyers) is one of our most-shipped engagement shapes for the Mid-Atlantic. The 12-week timeline holds steady; workstreams compress or expand in proportion; the metrics typically land within plus or minus 20 percent of the archetype above.

Five capabilities transfer directly to a comparable Baltimore engagement. First, Shopify Plus migration with FDA-aware product detail surfaces and structured Supplement Facts panels rendered from metafields. Second, subscription on dose-cadence SKUs that converts the top 30 to 40 percent of repeat customers into a high-LTV recurring base. Third, Klaviyo flow architecture that earns 25 to 30 percent of total revenue from email through dose-cadence segmentation. Fourth, bundle and dose-package merchandising that lifts AOV by 30 to 50 percent. Fifth, an evidence-citation content surface that links every dose claim to third-party studies inline.

Every Baltimore engagement starts with a 30-minute discovery call. Scope, timeline, and budget come back in writing within 48 hours. Eastern Time, same-day response Monday to Friday 9 to 6.